Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study

The Lancet Neurology - Tập 12 Số 2 - Trang 157-165 - 2013
Maarten J. Titulaer1,2, Lindsey McCracken1, Iñigo Gabilondo2, Thaís Armangué2, Carol Glaser3, Takahiro Iizuka4, Lawrence S. Honig5, Susanne M. Benseler6, Izumi Kawachi7, Eugenia Martínez‐Hernández1,8, Esther Aguilar2, Núria Gresa‐Arribas2, Nicole Ryan-Florance9, Abiguei Torrents10, Albert Saiz2, Myrna R. Rosenfeld1,2, Rita J. Balice‐Gordon1, Francesc Graus2, Josep Dalmau1,2,11
1Department of Neurology and Neurosciences, Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
2Department of Neurology, Hospital Clinic, The University of Barcelona (d'Investigacions Biomèdiques August Pi i Sunyer [IDIBAPS]), Spain
3California Department of Public Health, Richmond, CA, USA
4Department of Neurology, Kitasato University School of Medicine, Sagamihara, Japan
5Department of Neurology, Columbia University, New York, NY, USA
6Department of Rheumatology, Hospital of Sick Children, University of Toronto, ON, Canada
7Department of Neurology, Brain Research Institute, Niigata University, Japan
8Department of Neurology, Hospital Sant Pau, Universitat Autònoma de Barcelona, Spain
9Department of Neurology, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA
10Biostatistics and Data Management Platform, IDIBAPS, Hospital Clinic, Barcelona, Spain
11Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain

Tóm tắt

Từ khóa


Tài liệu tham khảo

Vitaliani, 2005, Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma, Ann Neurol, 58, 594, 10.1002/ana.20614

Dalmau, 2007, Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma, Ann Neurol, 61, 25, 10.1002/ana.21050

Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol, 7, 1091, 10.1016/S1474-4422(08)70224-2

Florance, 2009, Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents, Ann Neurol, 66, 11, 10.1002/ana.21756

Granerod, 2010, Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study, Lancet Infect Dis, 10, 835, 10.1016/S1473-3099(10)70222-X

Gable, 2012, The Frequency of autoimmune N-Methyl-D-Aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project, Clin Infect Dis, 54, 899, 10.1093/cid/cir1038

Krystal, 1994, Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses, Arch Gen Psychiatry, 51, 199, 10.1001/archpsyc.1994.03950030035004

Mohn, 1999, Mice with reduced NMDA receptor expression display behaviors related to schizophrenia, Cell, 98, 427, 10.1016/S0092-8674(00)81972-8

Hughes, 2010, Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis, J Neurosci, 30, 5866, 10.1523/JNEUROSCI.0167-10.2010

Mikasova, 2012, Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis, Brain, 135, 1606, 10.1093/brain/aws092

Irani, 2010, N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes, Brain, 133, 1655, 10.1093/brain/awq113

van Swieten, 1988, Interobserver agreement for the assessment of handicap in stroke patients, Stroke, 19, 604, 10.1161/01.STR.19.5.604

Verbeke, 2005

Tuzun, 2009, Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma, Acta Neuropathol, 118, 737, 10.1007/s00401-009-0582-4

Dabner, 2012, Ovarian teratoma associated with Anti-N-Methyl D-Aspartate receptor encephalitis: a report of 5 cases documenting prominent intratumoral lymphoid infiltrates, Int J Gynecol Pathol, 31, 429, 10.1097/PGP.0b013e31824a1de2

Titulaer, 2011, Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force, Eur J Neurol, 18, 19-e3, 10.1111/j.1468-1331.2010.03220.x

Sabin, 2008, Case records of the Massachusetts General Hospital. Case 26-2008. A 26-year-old woman with headache and behavioral changes, N Engl J Med, 359, 842, 10.1056/NEJMcpc0804644

Gabilondo, 2011, Analysis of relapses in anti-NMDAR encephalitis, Neurology, 77, 996, 10.1212/WNL.0b013e31822cfc6b

Lancaster, 2012, Neuronal autoantigens—pathogenesis, associated disorders and antibody testing, Nat Rev Neurol, 8, 380, 10.1038/nrneurol.2012.99

Chapman, 2011, Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment, Am J Psychiatry, 168, 245, 10.1176/appi.ajp.2010.10020181

Kayser, 2011, The emerging link between autoimmune disorders and neuropsychiatric disease, J Neuropsychiatry Clin Neurosci, 23, 90, 10.1176/appi.neuropsych.23.1.90

Pruss, 2012, IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment, Neurology, 78, 1743, 10.1212/WNL.0b013e318258300d

Pruss, 2012, NMDA receptor antibodies in herpes simplex encephalitis, Ann Neurol, 10.1002/ana.23689

1989